Baloxavir Marboxil

ATC J05AX25 · 11 markets · 29 records

Baloxavir Marboxil 11 markets · 29 records Forms

US 6 records · 5 strengths

40 mgtabletXofluza also in GB·AU·CA +3
80 mgtabletXofluza also in GB·AU·CA
40 mgpowderXofluza also in CN
40 mg/20 mLpowderXofluza
30 mgpowderXofluza

GB 4 records · 4 strengths

40 mgtabletXofluza also in US·AU·CA +3
20 mgtabletXofluza also in AU·CA·CN +1
80 mgtabletXofluza also in US·AU·CA
2 mgliquidXofluza 2mg/ml oral suspension

AU 4 records · 4 strengths

40 mgtabletXOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack also in US·GB·CA +3 unknown
20 mgtabletXOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack also in GB·CA·CN +1 unknown
80 mgtabletXOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack also in US·GB·CA unknown

Records without a stated strength · 1 Xofluza

HK 4 records · 1 strengths

Records without a stated strength · 1 Xofluza

CA 3 records · 3 strengths

40 mgtabletXofluza also in US·GB·AU +3
20 mgtabletXofluza also in GB·AU·CN +1
80 mgtabletXofluza also in US·GB·AU

CN 3 records · 3 strengths

40 mgtablet速福达玛巴洛沙韦 also in US·GB·AU +3
20 mgtablet速福达玛巴洛沙韦 also in GB·AU·CA +1
40 mgpowderManufacturer: Roche Pharma(Schweiz) AG also in US

SG 1 records · 1 strengths

40 mgtabletXofluza also in US·GB·AU +3

ES 1 records · 1 strengths

40 mgtabletXofluza also in US·GB·AU +3

TW 1 records · 1 strengths

20 mgtabletXofluza+1紓伏效膜衣錠20毫克 also in GB·AU·CA +1

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Xofluza

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	CN	ES	TW	HK	EU
40 mg tablet	Xofluza	Xofluza	Xofluza	XOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack	Xofluza	速福达玛巴洛沙韦	Xofluza	not recorded	not recorded	not recorded
20 mg tablet	not recorded	Xofluza	Xofluza	XOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack	not recorded	速福达玛巴洛沙韦	not recorded	Xofluza 紓伏效膜衣錠20毫克	not recorded	not recorded
80 mg tablet	Xofluza	Xofluza	Xofluza	XOFLUZA baloxavir marboxil 20 mg film-coated tablet blister pack	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
40 mg powder	Xofluza	not recorded	not recorded	not recorded	not recorded	Manufacturer: Roche Pharma(Schweiz) AG	not recorded	not recorded	not recorded	not recorded
2 mg liquid	not recorded	Xofluza 2mg/ml oral suspension	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
40 mg/20 mL powder	Xofluza	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
30 mg powder	Xofluza	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Xofluza	not recorded	not recorded	not recorded	not recorded	Xofluza	Xofluza

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.